These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 21655268

  • 1. Exendin-4 improves blood glucose control in both young and aging normal non-diabetic mice, possible contribution of beta cell independent effects.
    Fan R, Kang Z, He L, Chan J, Xu G.
    PLoS One; 2011; 6(5):e20443. PubMed ID: 21655268
    [Abstract] [Full Text] [Related]

  • 2. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
    Arakawa M, Ebato C, Mita T, Hirose T, Kawamori R, Fujitani Y, Watada H.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):809-14. PubMed ID: 19836346
    [Abstract] [Full Text] [Related]

  • 3. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice.
    Suen PM, Li K, Chan JC, Leung PS.
    Int J Biochem Cell Biol; 2006 Dec 18; 38(5-6):951-60. PubMed ID: 16172015
    [Abstract] [Full Text] [Related]

  • 4. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY, Kim YS, Ahn IS, Kim DS, Kang S, Hong SM, Park S.
    J Pharmacol Sci; 2009 Dec 18; 111(4):361-71. PubMed ID: 20019445
    [Abstract] [Full Text] [Related]

  • 5. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A, Winzell MS, Gorman T, Smith DM, Skrtic S, Hoeyem M, Abadpour S, Johansson L, Korsgren O, Foss A, Scholz H.
    PLoS One; 2015 Dec 18; 10(3):e0121204. PubMed ID: 25793295
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with EXf, a peptide analog of Exendin-4, improves β-cell function and survival in diabetic KKAy mice.
    Hou GJ, Li CN, Liu SN, Huan Y, Liu Q, Sun SJ, Li LY, Hou SC, Shen ZF.
    Peptides; 2013 Feb 18; 40():123-32. PubMed ID: 23353893
    [Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion.
    Bastien-Dionne PO, Valenti L, Kon N, Gu W, Buteau J.
    Diabetes; 2011 Dec 18; 60(12):3217-22. PubMed ID: 22013015
    [Abstract] [Full Text] [Related]

  • 8. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y, Zhou Y, Wang Y, Geng D, Liu J.
    Obes Surg; 2011 Sep 18; 21(9):1424-31. PubMed ID: 21479766
    [Abstract] [Full Text] [Related]

  • 9. Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.
    Juang JH, Kuo CH, Wu CH, Juang C.
    Cell Transplant; 2008 Sep 18; 17(6):641-7. PubMed ID: 18819252
    [Abstract] [Full Text] [Related]

  • 10. [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
    Zhao DX, Ma L, Shen ZA, Li DW, Shang YR, Yin K, Cheng WF, Wang X, Liu ZX.
    Zhonghua Shao Shang Za Zhi; 2016 Dec 20; 32(12):752-758. PubMed ID: 28043300
    [Abstract] [Full Text] [Related]

  • 11. Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation.
    Heller C, Kühn MC, Mülders-Opgenoorth B, Schott M, Willenberg HS, Scherbaum WA, Schinner S.
    Am J Physiol Endocrinol Metab; 2011 Nov 20; 301(5):E864-72. PubMed ID: 21771967
    [Abstract] [Full Text] [Related]

  • 12. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS, Ahrén B.
    J Mol Endocrinol; 2008 Feb 20; 40(2):93-100. PubMed ID: 18234911
    [Abstract] [Full Text] [Related]

  • 13. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
    Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Detroja J, Patel K, Gandhi T, Patel K, Bahekar R, Jain M.
    Pharmacol Rep; 2013 Feb 20; 65(4):927-36. PubMed ID: 24145087
    [Abstract] [Full Text] [Related]

  • 14. Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice.
    Hou S, Li C, Huan Y, Liu S, Liu Q, Sun S, Jiang Q, Jia C, Shen Z.
    J Diabetes Res; 2015 Feb 20; 2015():817839. PubMed ID: 26351642
    [Abstract] [Full Text] [Related]

  • 15. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
    Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC.
    Endocrinology; 2007 Nov 20; 148(11):5136-44. PubMed ID: 17673522
    [Abstract] [Full Text] [Related]

  • 16. Neonatal exendin-4 reduces growth, fat deposition and glucose tolerance during treatment in the intrauterine growth-restricted lamb.
    Gatford KL, Sulaiman SA, Mohammad SN, De Blasio MJ, Harland ML, Simmons RA, Owens JA.
    PLoS One; 2013 Nov 20; 8(2):e56553. PubMed ID: 23424667
    [Abstract] [Full Text] [Related]

  • 17. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N, Joharapurkar A, Shah G, Dhote V, Kshirsagar S, Bahekar R, Jain M.
    J Diabetes; 2012 Dec 20; 4(4):369-77. PubMed ID: 22356440
    [Abstract] [Full Text] [Related]

  • 18. Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats.
    Raab EL, Vuguin PM, Stoffers DA, Simmons RA.
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec 20; 297(6):R1785-94. PubMed ID: 19846744
    [Abstract] [Full Text] [Related]

  • 19. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, Pauli JR, Velloso LA.
    J Physiol; 2010 Jun 15; 588(Pt 12):2239-53. PubMed ID: 20421289
    [Abstract] [Full Text] [Related]

  • 20. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
    Park S, Hong SM, Sung SR.
    Life Sci; 2008 Feb 27; 82(9-10):503-11. PubMed ID: 18237751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.